The European Medicines Agency (EMA) has given the green light for the safe administration of a third dose of the modern vaccine from 18 years of age. This was announced by the body itself, in a note in which we read that a third dose of the modern vaccine, Spikevax, administered six or eight months after the second, favors an increase in antibodies in adults in which the level of defenses is reduced.
Vaccine Johnson & Johnson, Aifa decides on the 28th on recall. What the experts say
The EMA note also shows that at national level, public health bodies can issue official recommendations on the use of booster doses, taking into account the local epidemiological situation, as well as emerging data on efficacy and limited data on safety. the booster dose.
Modern vaccine effective on children aged 6 to 11: the company’s announcement
As for the risks of side effects, the data show that after the third dose, they remain similar to those of the second – notes Ema – and that in any case a careful monitoring of these phenomena will be carried out.
Covid vaccine, the adverse effects of the third dose comparable to those of the second
As stated in the note, EMA will continue to work closely with national authorities and the European Center for Disease Prevention and Control (ECDC) to evaluate the available data and provide recommendations to protect the public during the pandemic in course.
In the note from the agency, based in Amsterdam, it also refers that the decision to administer the third dose based on the local epidemiological situation and other information on efficacy and safety is a national competence.
Third dose, there is (yet) no reason to do it at all
by Antonio Cassone * and Roberto Cauda **
